Cargando…
Use of α1‐adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease
PURPOSE: Tamsulosin has been associated with dementia, but the results have been inconsistent. Concerns have been raised about using exposure assessment time too close to the outcome. We investigated the association between use of α1‐adrenoceptor antagonists indicated for benign prostate hyperplasia...
Autores principales: | Latvala, Laura, Tiihonen, Miia, Murtola, Teemu J., Hartikainen, Sirpa, Tolppanen, Anna‐Maija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542191/ https://www.ncbi.nlm.nih.gov/pubmed/35751619 http://dx.doi.org/10.1002/pds.5503 |
Ejemplares similares
-
β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study
por: Paakinaho, Anne, et al.
Publicado: (2023) -
Recent hospitalization and risk of antidepressant initiation in people with Parkinson’s disease
por: Hämäläinen, Iida, et al.
Publicado: (2022) -
Month and Season of Birth as a Risk Factor for Alzheimer’s Disease: A Nationwide Nested Case-control Study
por: Tolppanen, Anna-Maija, et al.
Publicado: (2016) -
Automated multi-dose dispensing in persons with and without Alzheimer’s disease—impacts on pharmacotherapy
por: Vallius, Sanna, et al.
Publicado: (2021) -
Opioid Use After Hospital Care due to Hip Fracture Among Community-Dwelling Persons With and Without Alzheimer’s Disease
por: Lintula, Eveliina, et al.
Publicado: (2019)